Bayer Investing In Indonesia On Growth Prospects
This article was originally published in PharmAsia News
Executive Summary
German pharmaceutical giant Bayer AG is investing EUR8.1 million to expand its drug manufacturing plant in Indonesia, with the aim of producing 50 million packs of medicines by 2020, its Indonesia chief said.